StockNews.com Initiates Coverage on Sangamo Therapeutics (NASDAQ:SGMO)
Stock analysts at StockNews.com started coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. A number of other research analysts also recently weighed in on SGMO. Royal Bank of Canada reiterated a “sector perform” rating and […]
Stock analysts at StockNews.com started coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. A number of other research analysts also recently weighed in on SGMO. Royal Bank of Canada reiterated a “sector perform” rating and […]
